What is the most recent earnings date for CLGN stock?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) last reported earnings on 11/26/2025.
COLLPLANT BIOTECHNOLOGIES LT (CLGN) Earnings History & Surprises
NASDAQ:CLGN • IL0004960188
Current stock price
0.585 USD
-0.01 (-1.18%)
At close:
0.5967 USD
+0.01 (+2%)
After Hours:
CLGN Earnings overview
Past quarterly earnings results for COLLPLANT BIOTECHNOLOGIES LT (CLGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.19
- Revenue Estimate
- 1.555M
Last Reported
Most Recent- Release Date
- Nov 26, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.27
- EPS Surprise
- -270.78%
- Revenue Surprise
- -98.44%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.27 | 0.16 | -270.78% | 28.95% | 77K | 4.941M | -98.44% | 1,825.00% |
| Q2 2025 | -0.28 | -0.14 | -96.08% | 24.32% | 179K | 2.595M | -93.10% | -28.11% |
| Q1 2025 | -0.13 | -0.04 | -218.63% | 64.86% | 2.055M | 2.698M | -23.83% | 1,996.94% |
| Q4 2024 | -0.34 | -0.28 | -21.21% | -41.67% | 164K | 440.64K | -62.78% | -45.15% |
| Q3 2024 | -0.38 | -0.29 | -30.72% | - | 4K | 424.32K | -99.06% | -90.70% |
| Q2 2024 | -0.37 | -0.28 | -34.35% | -175.51% | 249K | 408K | -38.97% | -97.55% |
| Q1 2024 | -0.37 | -0.36 | -3.64% | -12.12% | 98K | 612K | -83.99% | -77.37% |
| Q4 2023 | -0.24 | -0.07 | -236.13% | 36.84% | 299K | 8.735M | -96.58% | 398.33% |
| Q3 2023 | -0.38 | -0.13 | -186.58% | 5.00% | 43K | 3.566M | -98.79% | -60.91% |
| Q2 2023 | 0.49 | 0.02 | 3,102.61% | 225.64% | 10.184M | 5.255M | 93.80% | 14,448.57% |
| Q1 2023 | -0.33 | -0.30 | -11.56% | 8.33% | 433K | 245.82K | 76.15% | 518.57% |
| Q4 2022 | -0.38 | -0.32 | -18.27% | -26.67% | 60K | 51K | 17.65% | -80.65% |
| Q3 2022 | -0.40 | -0.32 | -26.50% | -37.93% | 110K | - | -21.43% | |
| Q2 2022 | -0.39 | -0.08 | -377.94% | -30.00% | 70K | 2.914M | -97.60% | -89.86% |
| Q1 2022 | -0.36 | -0.14 | -152.10% | -140.91% | 70K | 2.793M | -97.49% | -99.52% |
| Q4 2021 | -0.30 | -0.30 | -1.42% | 28.57% | 310K | - | -44.64% | |
| Q3 2021 | -0.29 | -0.29 | -1.54% | -514.29% | 140K | 125.46K | 11.59% | -96.63% |
| Q2 2021 | -0.30 | -0.10 | -194.12% | -50.00% | 690K | 3.167M | -78.21% | -15.85% |
| Q1 2021 | 0.88 | 0.52 | 70.84% | 466.67% | 14.5M | 10.26M | 41.33% | 2,277.05% |
| Q4 2020 | -0.42 | -0.31 | -37.25% | - | 560K | 290.19K | 92.98% | - |
| Q3 2020 | 0.07 | 0.94 | -92.54% | - | 4.15M | 11.966M | -65.32% | - |
| Q2 2020 | -0.20 | -0.16 | -26.50% | - | 820K | 1.57M | -47.77% | - |
| Q1 2020 | -0.24 | -0.23 | -2.30% | - | 610K | 714K | -14.57% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
0
Average EPS beat (4)
-151.67%
Max EPS beat (4)
-21.21%
Min EPS beat (4)
-270.78%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-69.54%
Max Revenue beat (4)
-23.83%
Min Revenue beat (4)
-98.44%
Analysis
In the last 4 quarters, CLGN has not beaten EPS estimates in any release
CLGN has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, CLGN reported -151.7% below the EPS estimates on average.
In the last 4 quarters, CLGN reported -69.5% below the revenue estimates on average.
Related analysis
COLLPLANT BIOTECHNOLOGIES LT / CLGN Earnings FAQ
Did CLGN stock beat earnings estimates in the most recent quarter?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often COLLPLANT BIOTECHNOLOGIES LT beats earnings estimates?
In the last 4 quarters, COLLPLANT BIOTECHNOLOGIES LT (CLGN) has beaten EPS estimates in 0 out of 4 releases.